Biotech & Medtech
Biotech & Medtech news — Saturday 21 November 2026
3 stories from 2 sources, every one in English. Each links to its publisher.
-
FDA again turns back Capricor Duchenne cell therapy
In an unusual statement, the FDA accused Capricor of “serious data integrity violations” that compromised its study findings and led to deramiocel’s second rejection since 2025.
-
Opinion: When should medical school start?
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith…
-
Opinion: How Kennedy and MAHA could help stop measles
A version of this article first appeared on the Substack of “ Why Should I Trust You? ” On Tuesday, after the United States lost its measles elimination status, health secretary Robert F. Kennedy Jr. posted on X that he wanted to stop…